3651 results for «259»
3651 results
Complex coronary artery disease: can stents and DCB be complementary?
16 May 2023 – From EuroPCR 2023
DES and DCB, can these two technologies be complementary for the treatment of the same patient? What are the advantages and how to proceed? You will know everything by watching this presentation based on concrete cases.
The importance of optimal vascular access and closure in TAVI patients
16 May 2023 – From EuroPCR 2023
In this session, a panel of experts focus on access and closure, a crucial aspect of TAVI. This discussion offers valuable insights into effective planning and achieving access for a TAVI procedure using echo guidance. It provides a step-by-step guide on closing a TAVI procedure using...
From proof to practice - Treating hypertension with ultrasound renal denervation
16 May 2023 – From EuroPCR 2023
Renal denervation: what are the latest clinical evidences and benefits? How to select the good candidate? How to establish a dedicated centre? All the anwers to these questions and more in this video.
Robotic PCI: real-life experience with a new robotic platform
16 May 2023 – From EuroPCR 2023
The current problems in interventional cardiology have been the same for years: exposure to X-rays, or orthopaedic injuries to operators after decades in the cathlab. The solution to these problems could lie in robotics and the increasing use of artificial intelligence in practice. Follow this session...
Lifetime management - Tailoring treatment options to secure future possibilities
16 May 2023 – From EuroPCR 2023
Check out this session if you want to better understand the importance of paravalvular leaks and conduction disorders after TAVI on long-term outcomes. You will also learn about the latest data on the lifetime management of patients with aortic stenosis, and value the importance of TAVI...
Physiologic guidance and optimisation in multivessel disease
16 May 2023 – From EuroPCR 2023
Follow the case study of this 70-year-old ex-smoker male patient with HTN, dyslipidemia, previous primary PCI to proximal and mid LAD because of anterolateral STEMI, presenting with syncope, and find out, through the debates around his treatment, how to use physiology in 2023.
Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform
16 May 2023 – From EuroPCR 2023
What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...
EuroPCR 2023 Welcome Ceremony
16 May 2023 – From EuroPCR 2023
As we celebrate the 30th anniversary of primary PCI for STEMI this year, follow the retrospective of this major advance in interventional cardiology, before listening to William Wijns, Jean Fajadet and their guests take stock of the current STEMI care worldwide at this opening ceremony which launches...
Treating diverse mitral regurgitation anatomies: the power of versatility
16 May 2023 – From EuroPCR 2023
Based on a LIVE mitral TEER educational procedure and several case examples, this MR patient session will allow you to learn more about the PASCAL platform and system, as well as the latest clinical and real-world data on mitral TEER using the PASCAL system, while benefiting...
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
